ArticleClinicoEconomics and outcomes research : CEOR2024

Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14).

Jorge Echeverri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.